Frank Stegert
Chief Investment Officer bei ATAI LIFE SCIENCES N.V.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Frank Stegert
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
| Public Company | Pharmaceuticals: Major | 10 | |
ATAI Life Sciences AG
 ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Frank Stegert
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Albright Stonebridge Group LLC
 Albright Stonebridge Group LLC Miscellaneous Commercial ServicesCommercial Services Albright Stonebridge Group engages in the provision of risk management services. It offers growth strategies, positioning, and strategic communications. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Undergraduate Degree | |
| BIONOMICS LIMITED | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Control Risks Group Ltd.
 Control Risks Group Ltd. Miscellaneous Commercial ServicesCommercial Services Control Risks Group Ltd. provides risk management consulting services. Its services include integrity risk, political risk, security risk and enterprise risk management. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| State University of New York at Albany | College/University | Doctorate Degree Undergraduate Degree | |
| University of Montréal | College/University | Doctorate Degree | |
| University of Denver | College/University | Graduate Degree Undergraduate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
| Century Foundation | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Center for American Progress
 Center for American Progress Miscellaneous Commercial ServicesCommercial Services The Center for American Progress is an advocacy organization. The non-profit company is based in Washington. The American company was founded by John D. Podesta. Patrick Gaspard has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The New School for Social Research | College/University | Undergraduate Degree | |
Social Risks LLC
 Social Risks LLC Miscellaneous Commercial ServicesCommercial Services Part of Control Risks International Ltd., Social Risks LLC provides research and advisory services. The company is based in New York, NY. Social Risks was acquired by Control Risks Group Ltd. on December 16, 2009. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pillar5 Pharma, Inc.
 Pillar5 Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| Asgaard Group Sverige AB | Corporate Officer/Principal | ||
| Friedman School of Nutrition Science & Policy | College/University | Director/Board Member | |
| DTHERA SCIENCES | Packaged Software | Director/Board Member Founder | |
Jackpocket, Inc.
 Jackpocket, Inc. Packaged SoftwareTechnology Services Jackpocket, Inc. engages in the development of a mobile application that allows users to buy lottery tickets. The company was founded by Matt Silber, Peter Sullivan, Leo Shemesh and Eric Parker in 2013 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
Chemomab Ltd.
 Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Biotechnology | Director/Board Member | |
Thiel Capital LLC
 Thiel Capital LLC Investment ManagersFinance Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California. | Investment Managers | Director/Board Member | |
Subversive Capital LLC
 Subversive Capital LLC Investment ManagersFinance Subversive Capital LLC (Subversive Capital) is a venture capital firm founded in 2013 by Michal Shtender and Michael B. Auerbach. The firm is headquartered in New York. | Investment Managers | Founder | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TILRAY BRANDS, INC. | Agricultural Commodities/Milling | Director/Board Member | |
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
IntroSpect Digital Therapeutics, Inc.
 IntroSpect Digital Therapeutics, Inc. BiotechnologyHealth Technology IntroSpect Digital Therapeutics, Inc. provides digital therapeutic platform for mental health care and support. The firm is designed to extend the life changing potential of psychedelics-assisted psychotherapy to patients in a scalable way. The company was founded by David Keene, Srinivas G. Rao and Florian Brand and is headquartered in San Diego, CA. | Biotechnology | Founder Chief Executive Officer Founder | |
Apeiron Investment Group Ltd. /Private Equity/
 Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Partners (Apeiron Partners) is a private equity/venture capital subsidiary of Apeiron Investment Group Ltd founded in 2012 by Nick Nigam. The firm is headquartered in Sliema, Malta. | Investment Managers | Founder Private Equity Investor Corporate Officer/Principal | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chairman | |
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
EntheogeniX Biosciences, Inc.
 EntheogeniX Biosciences, Inc. BiotechnologyHealth Technology EntheogeniX Biosciences, Inc. is a biotech company located in Wilmington, DE. EntheogeniX Biosciences is dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia. The joint venture company aims to innovate the mental healthcare system by harnessing the power of artificial intelligence and computational biophysics, along with a data-driven pipeline, to uncover new medicines from desired psychedelics to further help patients. EntheogeniX Biosciences is a partnership between atai life sciences and Cyclica. The company was founded by Naheed Kurji and is currently led by CEO Srinivas G. Rao since 2019. | Biotechnology | Chief Executive Officer Director/Board Member | |
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| Hassenfeld Childrens Hospital | Corporate Officer/Principal | ||
| Sophie Gerson Healthy Youth Foundation | Director/Board Member | ||
| Panopticon, Inc. | Chief Executive Officer | ||
| New York Collaborates For Autism, Inc. | Director/Board Member | ||
Subversive Real Estate Acquisition Reit Gp, Inc.
 Subversive Real Estate Acquisition Reit Gp, Inc. Real Estate Investment TrustsFinance Subversive Real Estate Acquisition Reit Gp, Inc. is a Canadian company that acts as a Real Estate Investment Trust/REIT. The private company is based in Vancouver, Canada. The CEO of the company is Michael B. Auerbach. | Real Estate Investment Trusts | Chief Executive Officer | |
| TUSCAN HOLDINGS CORP. II | Financial Conglomerates | Director/Board Member | |
| Leaf4life LLC | Director/Board Member | ||
| The University College of Osteopathy | College/University | Graduate Degree | |
Alloy Therapeutics LLC
 Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 36 |
| Kanada | 6 |
| Vereinigtes Königreich | 5 |
| Schweden | 3 |
| Australien | 2 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 10 |
| Finance | 9 |
| Commercial Services | 7 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 118 |
| Corporate Officer/Principal | 81 |
| Founder | 40 |
| Undergraduate Degree | 34 |
| Chief Executive Officer | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Christian Angermayer | 45 |
| Michael Auerbach | 30 |
| Srinivas Rao | 22 |
| John S. Marinucci | 19 |
| Sabrina Johnson | 17 |
| Florian Brand | 16 |
| Andrea Smiley | 15 |
| Amir Kalali | 12 |
| Aaron Weaver | 11 |
| Jason Camm | 11 |
| Ryan Barrett | 9 |
| David Keene | 9 |
| J. Boudreau | 7 |
| David Kideckel | 7 |
| Sarah McEwen | 6 |
- Börse
- Insiders
- Frank Stegert
- Unternehmensverbindungen
